Edwards Lifesciences Corporation (BVMF:E1WL34)
Brazil · Delayed Price · Currency is BRL 112.53
+0.88 (0.79%)
At close: Jan 15, 2026
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of 263.23 billion as of January 16, 2026. Its market cap has decreased by -3.55% in one year.
Market Cap
263.23B
Enterprise Value
246.33B
Revenue
31.36B
Ranking
n/a
PE Ratio
36.11
Stock Price
112.53
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 1.67B to 263.23B, an increase of 15,670.90%. That is a compound annual growth rate of 21.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 263.23B | -3.40% |
| Dec 31, 2025 | 272.48B | 0.90% |
| Dec 31, 2024 | 270.05B | 20.34% |
| Dec 29, 2023 | 224.40B | -7.98% |
| Dec 30, 2022 | 243.86B | -45.89% |
| Dec 31, 2021 | 450.65B | 52.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 88.98B |
| Raia Drogasil | 43.24B |
| Hypera | 14.95B |
| Fleury | 8.57B |
| Odontoprev | 5.83B |
| Diagnósticos da América | 4.76B |
| Empreendimentos Pague Menos | 4.26B |
| Blau Farmacêutica | 2.71B |